Knott David M decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 10.1% during the 1st quarter, HoldingsChannel reports. The fund owned 8,901 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the period. Knott David M’s holdings in Gilead Sciences were worth $671,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Wealthcare Advisory Partners LLC bought a new position in Gilead Sciences in the 3rd quarter valued at approximately $133,000. Advisors Preferred LLC bought a new position in Gilead Sciences in the 1st quarter valued at approximately $140,000. Stelac Advisory Services LLC bought a new position in Gilead Sciences in the 1st quarter valued at approximately $141,000. Certified Advisory Corp bought a new position in Gilead Sciences in the 4th quarter valued at approximately $133,000. Finally, Mckinley Capital Management LLC Delaware lifted its stake in Gilead Sciences by 67.7% in the 1st quarter. Mckinley Capital Management LLC Delaware now owns 2,130 shares of the biopharmaceutical company’s stock valued at $161,000 after purchasing an additional 860 shares during the last quarter. 77.71% of the stock is owned by institutional investors and hedge funds.
Top Value Stocks To Own Right Now: Access National Corporation(ANCX)
- [By Ethan Ryder]
Shares of Access National Co. (NASDAQ:ANCX) have been given an average rating of “Hold” by the eight ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $31.00.
Top Value Stocks To Own Right Now: ClearBridge American Energy MLP Fund Inc.(CBA )
- [By Ethan Ryder]
News headlines about ClearBridge American Energy MLP Fund (NYSE:CBA) have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ClearBridge American Energy MLP Fund earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the investment management company an impact score of 47.3026009142931 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Top Value Stocks To Own Right Now: Pebblebrook Hotel Trust(PEB)
- [By Joseph Griffin]
These are some of the news stories that may have effected Accern’s analysis:
Get Pebblebrook Hotel alerts:
Pebblebrook Hotel (PEB) Expected to Post Quarterly Sales of $206.07 Million (americanbankingnews.com) Keep Company Secrets Safe With a Strong Publishing Process (cmswire.com) Analysts Anticipate Pebblebrook Hotel (PEB) to Post $0.73 Earnings Per Share (americanbankingnews.com) Pebblebrook Hotel Forecasted to Earn Q2 2018 Earnings of $0.72 Per Share (PEB) (americanbankingnews.com)
A number of brokerages recently issued reports on PEB. Boenning Scattergood restated a “hold” rating on shares of Pebblebrook Hotel in a report on Monday, April 30th. Zacks Investment Research upgraded Pebblebrook Hotel from a “hold” rating to a “strong-buy” rating and set a $40.00 target price on the stock in a report on Wednesday, May 2nd. Robert W. Baird lifted their target price on Pebblebrook Hotel from $37.00 to $38.00 and gave the stock a “hold” rating in a report on Tuesday, May 1st. Finally, ValuEngine cut Pebblebrook Hotel from a “strong-buy” rating to a “buy” rating in a report on Monday, April 2nd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Pebblebrook Hotel presently has an average rating of “Buy” and a consensus price target of $36.61.
- [By Max Byerly]
Pebblebrook Hotel Trust (NYSE:PEB) has received a consensus rating of “Hold” from the thirteen research firms that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $36.19.
- [By Matthew DiLallo]
Improving business travel demand during the first quarter drove Pebblebrook Hotel Trust (NYSE:PEB) to update its outlook earlier this month. Those travel trends turned out to be stronger than even its more optimistic expectations, helping the company to deliver results that were above the updated forecast. Because of that, the company is even more encouraged about what lies ahead in 2018.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Pebblebrook Hotel (PEB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com